Searche

Your search for "editing" matched 280 page(s).

Showing results 231 to 240.

Speaking your patients’ language – Is it really worth it? The impact of translation on multilingual patient education materials - Volume 33, Issue

This article discusses the role of translation and its impact on the success of patient education materials, particularly in the context of patient recruitment and retention for clinical trials. We examine how translation and localisation help…

President’s Message - Volume 33, Issue

See you in Valencia… Time is flying. We just left the autumn conference and now are approaching our main EMWA event – the spring conference, to take place May 7– 11, 2024. This time we go to Valencia, and I am sure that no one needs to be…

Outgoing President's Message - Volume 33, Issue

Time flies – nothing new in that then! The year of my presidency is finished, so it is time to look back and summarise. It was my first task as a president to introduce a 5-year strategic plan for 2023–2027, and together with the whole Executive…

Connecting through screens: Navigating relationships with patients and advocacy groups in a digital world - Volume 33, Issue

As a Healthcare Publications Editor at Karger Publishers, I write, edit, and oversee the development of patient information resources in our Fast Facts for Patients series. Soft skills are vital in my role at Karger, where we are committed to…

Incoming President's Message - Volume 31, Issue

Dear EMWA friends and colleagues, as I draft this message, we are coming to the close of EMWA’s 53rd conference in Berlin, Germany. By all measures, it was a great conference with almost 400 delegates participating in our full programme…

Wait! What? There’s stuff missing from the scholarly record? - Volume 31, Issue

The scholarly record is an ever-evolving network – or graph – of truth assertions on which each discipline bases its discussions, and against which each discipline measures its progress. But what if the scholarly record is missing a significant…

To bias or not to bias in oncology clinical trials: Perspectives on design, endpoint selection, and reporting - Volume 32, Issue

Developing drugs for cancer is a process as complex as the disease itself. At the planning stage of a clinical trial for an oncology drug, thorough and careful consideration must be given to choosing the right study design and endpoints/estimands,…

The unique challenges of clinical trials in rare disease: A regulatory writer’s perspective - Volume 32, Issue

Designing clinical trials in rare diseases comes with a specific set of challenges including limited knowledge around the natural history of a disease, small sample size available for trial participation, regulatory guidance that is not calibrated…

The Crofter: Sustainable Communications - Volume 32, Issue

Sustainable supply As medical writers/ communicators who provide services to pharmaceutical companies, we are part of a pharmaceutical company’s supply chain. In this issue, we follow-up on EMWA’s November 2022 Expert Series Seminar (ESS) on…

EMA Foreword - Volume 32, Issue

The EU Clinical Trials Regulation and its much-anticipated benefits: Foreword from the European Medicines Agency The year 2022 signalled the beginning of a new way of handling clinical trials in Europe, with the implementation of the EU Clinical…

Visit the EMWA website

Search

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Scope

Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.

Medical Writing is listed in the following indexes: